InvestorsHub Logo
Followers 6
Posts 130
Boards Moderated 0
Alias Born 01/25/2014

Re: Gsdubb post# 4758

Monday, 02/03/2014 9:56:22 AM

Monday, February 03, 2014 9:56:22 AM

Post# of 106838
Very true...and then there is the possibility BioLeonhardt's stem cell pump-device is utilized to also deliver MyoCell to necrotic myocardium. Things appear to be much more connected than at first glance. If investors do their due diligence and participate in quality research of the company, it's history in the stem cell arena, and the MyoCell technology (clinical trials to date, safety/efficacy results, etc.) it is difficult to not see the potential. One would have to be biased against proven factual information to determine otherwise.